Repligen Merging with Spectrum Labs in $359M Deal

06:57 EDT 23 Jun 2017 | Genetic Engineering News

Repligen said today it plans to merge with privately-held Spectrum Laboratories, in an approximately $359 million deal that Repligen said will accelerate the growth of its filtration business and enhance its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing. Based in Rancho Dominguez, CA, Spectrum specializes in developing bioprocess filtration technologies; its offerings include hollow fiber (HF) tangential flow filtration (TFF) products and associated systems and consumables. The merger with Spectrum is Repligen’s second expansion in less than a year, and its third in 14 months. Repligen reasons that adding Spectrum hollow fiber TFF products and associated R&D expertise directly addresses a gap in Repligen’s XCell™ ATF filtration portfolio—namely consumables—and will provide Repligen with a unique opportunity to develop new products that address customer needs in bioprocessing. Repligen said the merger would complement and strengthen its position in the filtration market, ...

Original Article: Repligen Merging with Spectrum Labs in $359M Deal


More From BioPortfolio on "Repligen Merging with Spectrum Labs in $359M Deal"

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...